Burton Berkson, MD, MS, PhD - Cancers and Autoimmune Disease (2013 Conference) (LDN, low dose naltrexone)

Deanna Windham, DO - LDN in Allergies, Autoimmune Disease and Pediatrics (2013 Conference) (LDN, low dose naltrexone)

Deanna Windham, DO - Case Studies (2013 Conference) (LDN, low dose naltrexone)

Jill Smith, MD - Inflammatory Bowel Disease (2013 Conference) (LDN, low dose naltrexone)

Paul Battle, PA-C - Potential Applications for LDN (2013 Conference) (LDN, low dose naltrexone)

Tom Gilhooly, MBChB, MRCGP - LDN in Practice (2013 Conference) (LDN, low dose naltrexone)

Mark Shuhkman, MD and Andrey Lev-Weissberg, MD - Psychiatric Disorders (2013 Conference) (LDN, low dose naltrexone)

Friday afternoon Q & A (2017 Conference) (LDN, low dose naltrexone)

Questions on use of LDN in psoriasis, Lyme Disease, cancer, thyroid, diabetes, Crohn’s, MS, Lyme, vitiligo, other autoimmune diseases, administration route, dosing, nutrition, environmental toxins, LDN receptors, thymus proteins, peptides, stem cells, Vitamin D, insurance coverage for LDN, resources for testing and other treatments.

Saturday morning Q & A (2017 Conference) (LDN, low dose naltrexone)